Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

Details

Ressource 1Download: 38448792_BIB_8A325C52A9E1.pdf (525.23 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_8A325C52A9E1
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Journal
Nature medicine
Author(s)
Verschoor Y.L., van de Haar J., van den Berg J.G., van Sandick J.W., Kodach L.L., van Dieren J.M., Balduzzi S., Grootscholten C., IJsselsteijn M.E., Veenhof AAFA, Hartemink K.J., Vollebergh M.A., Jurdi A., Sharma S., Spickard E., Owers E.C., Bartels-Rutten A., den Hartog P., de Miranda NFCC, van Leerdam M.E., Haanen JBAG, Schumacher T.N., Voest E.E., Chalabi M.
ISSN
1546-170X (Electronic)
ISSN-L
1078-8956
Publication state
Published
Issued date
05/2024
Peer-reviewed
Oui
Volume
30
Number
5
Pages
1499
Language
english
Notes
Publication types: Published Erratum
Publication Status: ppublish
URN
urn:nbn:ch:serval-BIB_8A325C52A9E10
OAI-PMH
oai:serval.unil.ch:BIB_8A325C52A9E1
DOI
10.1038/s41591-024-02898-8
Pubmed
38448792
Web of science
001180556000001
Open Access
Yes
Create date
08/03/2024 15:13
Last modification date
09/08/2024 15:02
Usage data